che-chandler.de
Atlas of Rheumatoid Arthritis
Beschreibung:
Professor Paul Emery is the Arthritis Research UK Professor of Rheumatology and Director of
the Leeds Institute of Rheumatic and Musculoskeletal Medicine and the Director of the Leeds
Musculoskeletal Biomedical Research Unit at Leeds Teaching Hospitals Trust in Leeds, United
Kingdom. Professor Emery was the President of the European League Against Rheumatism
(EULAR) from 2009-2011 and has served on the editorial boards major rheumatology journals
including Rheumatology, Arthritis and Rheumatism, Annals of the Rheumatic Diseases, Clinical
and Experimental Rheumatology, and Clinical Rheumatology. He was the inaugural President of
International Extremity MRI Society (ISEMIR) and is a National Institute for Health Research
(NIHR) Senior Investigator. Professor Emery is a recipient of the Roche Biennial Award for
Clinical Rheumatology; the Rheumatology Hospital Doctor of the Year Award; the EULAR
Prize for outstanding contribution to rheumatology research; and the Carol Nachman Prize
for outstanding rheumatology research. Professor Emery's research interests center around the
immunopathogenesis and immunotherapy of rheumatoid arthritis, spondyloarthritis, and connective
tissue diseases. He has a special interest in the factors leading to persistent inflammation
and has published over 950 peer-reviewed articles in this area.
is the Arthritis Research UK Professor of Rheumatology and Directorofthe Leeds Institute of Rheumatic and Musculoskeletal Medicine and the Director of the Leeds
Musculoskeletal Biomedical Research Unit at Leeds Teaching Hospitals Trust in Leeds, United
Kingdom. Professor Emery was the President of the European League Against Rheumatism
(EULAR) from 2009-2011 and has served on the editorial boards major rheumatology journals
including Rheumatology, Arthritis and Rheumatism, Annals of the Rheumatic Diseases, Clinical
and Experimental Rheumatology, and Clinical Rheumatology. He was the inaugural President of
International Extremity MRI Society (ISEMIR) and is a National Institute for Health Research
(NIHR) Senior Investigator. Professor Emery is a recipient of the Roche Biennial Award for
Clinical Rheumatology; the Rheumatology Hospital Doctor of the Year Award; the EULAR
Prize for outstanding contribution to rheumatology research; and the Carol Nachman Prize
for outstanding rheumatology research. Professor Emery's research interests center around the
immunopathogenesis and immunotherapy of rheumatoid arthritis, spondyloarthritis, and connective
tissue diseases. He has a special interest in the factors leading to persistent inflammation
and has published over 950 peer-reviewed articles in this area.
The Atlas of Rheumatoid Arthritis will provide clinicians with a visual guide to rheumatoid arthritis, focusing on assessment, diagnosis and treatment, including newer research into the signalling pathways involved in the pathogenesis of RA, before focusing on the treatment of RA.
Rheumatoid arthritis (RA) is the most common and most serious of the inflammatory arthritic disorders, and it dominates clinical rheumatological practice. Effective, early treatment is vital as this can slow the course of the disease and reduce joint damage. RA is usually treated using disease-modifying anti-rheumatic drugs (DMARDs), most commonly methotrexate. The newest treatments target the disease-causing immune elements specifically and directly.